Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 20 Dec 19 EFFECT Notice of effectiveness
- 19 Dec 19 424B3 Prospectus supplement
- 18 Dec 19 S-4/A Registration of securities issued in business combination transactions (amended)
- 16 Dec 19 S-4/A Registration of securities issued in business combination transactions (amended)
-
4 Dec 19 S-4/A Registration of securities issued in business combination transactions (amended)
- 6 Nov 19 S-4 Registration of securities issued in business combination transactions
TARA similar filings
Filing view
External links
December 4, 2019
Proteon Therapeutics, Inc.
200 West Street
Waltham, MA 02451
Consent to Reference in Proxy Statement/Prospectus
Proteon Therapeutics, Inc. (the “Company”) has filed a Registration Statement on Form S-4, as amended, with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), as of the date hereof. In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.
Sincerely, |
|
|
|
/s/ Gregory P. Sargen |
|
Name: Gregory P. Sargen |
|